Castle Biosciences (CSTL)
NASDAQ:CSTL
US Market
Advertisement

Castle Biosciences (CSTL) Revenue

Compare
450 Followers

Castle Biosciences Revenue

Castle Biosciences had a revenue of 83.04M in the quarter ending Sep 30, 2025, with -3.65%. This bring the company's revenue in the last twelve months to 343.53M, Increased -0.79%. In the fiscal year ending Dec 31, 2024, Castle Biosciences had annual revenue of 332.07M with 51.09% growth.
Revenue (ttm)
343.53M
Revenue Growth
10.15%
P/S Ratio
3.05
Revenue/Employee
$423,557
Employees
784
Market Cap
$1.01B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
332.07M112.28M+151.09%
Dec 31, 2023
219.79M82.75M+160.38%
Dec 31, 2022
137.04M42.95M+145.65%
Dec 31, 2021
94.08M31.44M+150.18%
Dec 31, 2020
62.65M10.78M+120.79%
Dec 31, 2019
51.87M29.08M+227.62%
Dec 31, 2018
22.79M9.03M+165.67%
Dec 31, 2017
13.75M
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis